EC Number | Application | Comment | Organism |
---|---|---|---|
1.3.1.98 | medicine | computional design of 3-D structures of MurB enzymes and docking studies will provide highly useful information towards rational design of new tuberculosis drugs through experimental research design for further formulations as per pharmaceutical norms | Mycobacterium tuberculosis |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
1.3.1.98 | sequence alignment with Escherichia coli structures, PDB entries 2Q85 and 2MBR, and modeling of structure as well as docking with N-acetylpyruvyl glucosamine | Mycobacterium tuberculosis |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.3.1.98 | Mycobacterium tuberculosis | - |
- |
- |
1.3.1.98 | Mycobacterium tuberculosis | B5AFK3 | - |
- |
1.3.1.98 | Mycobacterium tuberculosis H37Rv | B5AFK3 | - |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.3.1.98 | UDP-N-acetylenolpyruvylglucosamine + NADPH | complex of MurB and substrate forms strong hydrogen bond with Arg176, Ser257 and Glu361. The secondary structure of MurB consists of 13 helices, 6 beta sheets, 6 beta hairpins, 5 beta bluges, 19 stands, 52 beta turns and 4 inverse gamma turns | Mycobacterium tuberculosis | UDP-N-acetylmuramic acid + NADP+ | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.3.1.98 | MurB | - |
Mycobacterium tuberculosis |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.3.1.98 | FAD | - |
Mycobacterium tuberculosis |